KPKishanta Kumar Pradhan

Kishanta Kumar Pradhan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kishanta Kumar Pradhan has a total of 37 co-authors. Here are the top co-authors by number of shared publications:

  • Naresh Kumar Rangra

    Chitkara University School of Pharmacy, Chitkara University, Himachal Pradesh, India

    2 shared publications
  • Subir Samanta

    Department of Pharmaceutical Sciences and Technology, Division of Pharmaceutical Chemistry, Birla Institute of Technology, Mesra, Ranchi, Jharkhand, India

    2 shared publications
  • Alakh N. Sahu

    Department of Pharmaceutical Engineering and Technology , IIT (BHU) , Varanasi , India

    1 shared publication
  • Anant Nag

    Department of Pharmaceutical Sciences and Technology Birla Institute of Technology Ranchi Jharkhand India

    1 shared publication
  • Arjun Patra

    Department of Pharmacy , Guru Ghasidas Vishwavidyalaya , Bilaspur , India

    1 shared publication
  • Ashok K Pattnaik

    Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Ranchi, Jharkhand, India

    1 shared publication

Latest Publications

  • Open Access

    Indian Knowledge Systems (IKS) for Pharmacy, Pharmaceutical Sciences, and Drug Discovery

    by Kishanta Kumar Pradhan, Rojalini Samanta, Rakhi Mishra, Subhashree Sahoo

    The introduction of Indian Knowledge Systems (IKS) in the modern Pharmaceutical Education is a landmark achievement for the Higher Education system in India, which definitely finds its foundation stone in the vision of the National Education Policy (NEP) 2020. Conceived as a link between India's ancient pharmaceutical history and the challenging requirements of the present day drug discovery and development activities, this book entitled Indian Knowledge Systems for Pharmacy, Pharmaceutical Sciences, and Drug Discovery will serve as a structured guide for Pharmacy students, teachers and researchers. Starting from the original texts of Charaka Samhita and Sushruta Samhita philosophies of Indian medical thought, including the concept of Tridosha, Panchamahabhuta, and the idea of personalized medicine based on Prakriti, is traced, and the implications of these in the present era of pharmaceutical classification and formulation science are discussed. It delves deep into the plural medical heritage of India, including Ayurveda, Siddha medicine, Unani medicine, Yoga therapy, SowaRigpa and folk medicine and all within the context of the regulatory framework of AYUSH. History and philosophy aside, this book deals seriously with the science of the pharmaceuticals. The chapters on medicinal plant knowledge and documentation (Dravyaguna Vigyan), and ethnopharmacology seek to fill in the gaps in this knowledge, and apart from chapters on Rasashastra and Herbo-mineral medicine, it welcomes nanomedicine, standardization, and safety assessment. The book also highlights the latest methodological approaches, such as reverse pharmacology, network pharmacology, systems biology, artificial intelligence, bioinformatics, and omics technologies, and makes Digital Ayurveda as a truly new research border of interdisciplinary research. The text acknowledges that traditional knowledge needs to be validated by robust science, so also covers, in detail, clinical research methodology, translational medicine, integrative therapeutics and pharmacovigilance, as well as practical issues like novel drug delivery systems, nutraceuticals and functional foods, and intellectual property rights in traditional knowledge commercialization. The concluding chapters dedicated to green pharmacy, sustainable drug development, biodiversity conservation, and One Health approach, underscore the global imperative for ethical, ecological, and equitable pharmaceutical innovation. This book is intended for undergraduate and postgraduate students from the field of Pharmacy while following the NEP 2020 curriculum, teachers and faculty developing content to incorporate IKS in the curriculum and for researchers to get a scholarly and easily accessible touch-point into the traditional field of Pharmacy sciences in India. These chapters are a blend of historical background and modern science, with case studies and future vision on research infrastructure, industry linkages and global market potential of Indian traditional products in healthcare. We hope that this work will achieve the curricular objectives, but also foster a new generation of pharmacy professionals who think beyond the idea of Indian Knowledge Systems and appreciate its contribution, as an evolving system, to the modern drug discovery, where ancient knowledge and scientific research walk hand in hand.

  • Process Engineering and Therapeutic Insights Into Acacia catechu (Kattha) Extracts: Sustainable Technologies and Functional Food Potential With Focus on Hemorrhoids

    by Anant Nag, Kishanta Kumar Pradhan

    Acacia catechu (kattha) heartwood is used for a long time in Ayurveda medicine for the treatment of digestive and vascular disorders, particularly hemorrhoids. Its medicinal value has a high presence of polyphenol substances offering many properties in pharmacy. Besides the folk medicine, kattha is a promising food ingredient and also for the development of nutraceutical products. When it is compared to typical water extraction with MAE and UAE methods, the extraction time is reduced by a factor of 70% and there are fewer solvents which are used by almost 60%, showing a greater industry use possibility. But still the challenges remain for the standardization of dosage, ensuring the stability, large‐scale manufacturing and also regulatory requirements. This review is combining the field of ethnopharmacological information, together with developments in process engineering, to prove that kattha is a possible source of sustainable bioactive polyphenolic elements. The range of applications includes functional drinks, dietary supplements, and phytomedicine products, with hemorrhoid management as one of the many examples. By linking the old traditional understanding with the process engineering of modern food, kattha becomes a multi‐use choice for innovations in the nutraceuticals field which ensure food security goals, better health for the public, and much more sustainable nutrition.

  • Open Access

    Green synthesis of silver-doped CuO/CaO/ZnO nanocomposites using extract of Dalbergia sissoo, their characterization, and various applications

    by Supurna Panda, Heena Mahanand, Megha Acharya, Sinchan Das, Varsha Yadav, Lopamudra, Vivekananda Mandal, Swaha Satpathy, Kishanta Kumar Pradhan, Sanjay Kumar Mehta, et al.

    In this study, Dalbergia sissoo extract mediated Ag-doped CuO/CaO/ZnO nanocomposites (Ag–CuO–CaO–ZnO NCs) were synthesized using an eco-friendly approach. FTIR confirmed phytochemical-assisted reduction, while UV–Vis spectroscopy revealed a characteristic peak at 246 nm, indicating the formation of the nanocomposite. XRD and SAED revealed the crystalline structure, and SEM/TEM revealed predominantly hexagonal particles. TEM and DLS analyses revealed particle sizes ranging from 10 to 100 nm, with an average size of approximately 26 nm. EDX verified successful silver incorporation, and DSC was used to assess thermal stability. The DSAgNCs showed antioxidant activity and demonstrated potent cytotoxicity against C6 glioblastoma cells (IC 50 = 37.29 μg/mL). The Ag–CuO–CaO–ZnO NCs also exhibited significant antibacterial activity against Escherichia coli . After 120 min, the functional performance of the Ag–CuO–CaO–ZnO NCs was evaluated through the photocatalytic degradation of organic dyes including crystal violet (CV), and malachite green (MG) under light irradiation, resulting in degradation percentages of 90 and 92 %, respectively. In addition, the metal-ion sensing ability of the Ag–CuO–CaO–ZnO NCs was investigated against different metal salts, which were highly sensitive to Cd 2+ , Ca 2+ , Zn 2+ , Ni 2+ , Sr 2+ , Mg 2+ , Co 2+ , and Al 3+ . Overall, the results highlight that Ag–CuO–CaO–ZnO NCs possess multifunctional photocatalytic, sensing, and biological properties suitable for environmental remediation and biomedical applications.

  • Open Access

    Development and Validation of a Stability Indicating HPTLC Method for Simultaneous Estimation of Telmisartan and Gallic Acid as per ICH Q1A (R2)

    by Swadesh Kumar Pattanik, Kishanta Kumar Pradhan

    Background A simple, selective and sensitive HPTLC method was developed for simultaneous estimation of Telmisartan (TEL) and Gallic acid (GA). Oxidative stress produces hypertension, GA having antioxidative property that reduces ROS. TEL is safer angiotensin-1 receptor blocker. Objectives Literatures suggest antioxidant with cardiovascular drug produce synergistic effect. Materials and Methods The stationary-phase used was aluminium-backed silica gel 60F254 HPTLC plates (20 cm×10 cm, thickness-0.2 mm). The mobile-phase consisted of ethyl acetate: methanol: chloroform: acetic acid in the ratio of 4:2:2:0.2(v/v). Drugs were exposed to different stress conditions (Acid, Alkali, Oxidative, Thermal and Photolytic) for 8 hr, analysed at intervals of 2 hr. Detection and quantification were performed densitometrically (200-400 nm). Results Calibration plots showed good linear relation, with better correlation coefficient (R2). AUC of the drugs were between the concentration ranges of 200-1200 ng/spot. For GA, Rf value was 0.60, LOD-5.494 ng/spot, and LOQ-16.65 ng/spot. For TEL, Rf value was 0.67, LOD-19.877 ng/ spot, and LOQ-60.235 ng/spot. In alkaline solution, TEL degraded up to 12.5%, and GA degraded completely. Whereas, in oxidative environment 30% and 30.55% degradation of TEL and GA were noted. Conclusion Developed method was validated as per ICH guidelines, the performed forced degradation study will help for drug stability and formulation development.

  • A validated bioanalytical method for the simultaneous estimation of telmisartan and gallic acid in rat plasma samples by high‐performance thin‐layer chromatography–mass spectrometry: Application to an oral pharmacokinetic study

    by Swadesh Kumar Pattanik, Kishanta Kumar Pradhan

    A novel and cost‐effective high‐performance thin‐layer chromatography (HPTLC) method, combined with densitometric quantification, was developed for the biomedical analysis of telmisartan (TEL) and gallic acid (GA). Recent research indicates that when used in combination, these compounds offer improved therapeutic efficacy for the treatment of cardiovascular diseases with reduced side effects. The study focused on the simultaneous quantification and pharmacokinetic analysis of drugs in rat plasma. The separation was conducted using HPTLC silica gel 60 F254 plates with dimensions of 20 × 10 cm and a thickness of 0.2 mm. The mobile phase used for separation consisted of a mixture of ethyl acetate, methanol, chloroform, and acetic acid in the ratio of 4:2:2:0.2 (v/v). GA and TEL were analyzed using ultraviolet detection at specific wavelengths, with GA at 280 nm and TEL at 296 nm. Peak purity was assessed through spectral correlation analysis using Vision CATS software. The method underwent validation following the guidelines of the US Food and Drug Administration (US FDA). Calibration plots demonstrated linearity in the concentration range of 200–1200 ng/spot, with high correlation coefficients (R2). The retention factors (Rf) were 0.67 for TEL and 0.60 for GA. The identity of the separated compounds was further confirmed using MS, with GA having a mass‐to‐charge ratio (m/z) of 168.9 in negative mode and TEL with m/z 515.2 in positive mode. In the pharmacokinetic study, the maximum peak plasma concentration (Cmax) for GA was 899.7 ng/mL, and for TEL, it was 1013 ng/mL. The time to reach maximum concentration (Tmax) was 2 h for GA and 6 h for TEL. This simultaneous qualitative and quantitative determination of the drugs in an oral pharmacokinetic study involving Wistar rats can serve as a valuable tool for future investigations into pharmacokinetic interactions, quality control, and routine analysis of these drugs, both in their pure forms and in novel formulations.


  • Evaluation of Acacia auriculiformis Benth. leaves for wound healing activity in type 2 diabetic rats

    by Kishanta Kumar Pradhan, Naresh Kumar Rangra, Subir Samanta

    Background: Acacia auriculiformis Benth. is a perennial shrub which has been traditionally known to treat various medical complications such as sore eyes, allergy, rheumatism, sore eyes, and rashes. Objectives: The current study is designed to decipher a shred of clinical confirmation and biochemical support for wound-healing efficacy of methanolic leaves extract of A. auriculiformis. Materials and Methods: We prepared the leaves extract in different solvents, i.e., petroleum ether, chloroform, ethyl acetate, acetone, butanol, and methanol. The in vitro studies were carried out on the above leaf's extracts using α-glucosidase and α-amylase inhibition in vitro antidiabetic assays. Animal model of streptozotocin-induced diabetes was used in the 0-, 7-, and 15-day studies, respectively. The comparison study was carried out in diabetic wound control in respect of the period of epithelialization, %wound contraction, and hydroxyproline content in the excision wound model. However, the breaking strength parameter was used to calculate healing potential in the incision wound model. The bioactive methanol extract was subjected to LC-MS/MS analysis to characterize the phytoconstituents responsible for pharmacological activity. Results: The methanolic leaves extract showed the highest percentage inhibition of 94.259% and 95.259% in α-glucosidase and α-amylase in vitro antidiabetic assays, respectively. The high content of collagen fibers and stronger epithelial cells growth were observed in histopathological studies of hydrogel containing methanolic leaves extract as compared to the diabetic wound control and standard. Subsequently, for investigating the biological impact upon live cells, cytotoxicity study was tested in different cell lines (A549, HEK-293, and MCF-7). Cytotoxic results showed that greater than 75% of cells were visible in all the cell lines, which gives the confirmation of biocapability of the extract. The LC-MS/MS results revealed the presence of compounds such as β-sitosterol, lupeol, stigmasterol, and quercetin. Conclusion: A. auriculiformis is a potent medicinal plant that can be further utilized as a complementary and alternative therapy for the treatment of diabetes-induced wounds and the management of oxidative stress and diabetes.


  • Open Access

    Wound Healing Activity of Gel Formulated Leaves Extract of Neolamarckia cadamba (Roxb) Bosser

    by Shruti Nayan, Chanchal Kumar Mishra, Divya Priyadarshini, Kishanta Kumar Pradhan, Manik Ghosh, Ashok Pattnaik


  • Open Access

    In vivo Antiinflammatory Potential of Leaf Extracts of Acacia auriculiformis Benth.

    by N. K. Rangra, S. Samanta, K. K. Pradhan

    The prime objective of the present study was to evaluate the probable in vivo antiinflammatory potential of various extracts of the leaves of Acacia auriculiformis Benth. using carrageenan and formalin-induced inflammation in the rats. Thereafter gas chromatography-mass spectrometry analysis of the bioactive extract was performed to identify the compounds responsible for the antiinflammatory activity. The in vitro antioxidant potential was determined through 2,2-diphenyl-1-picrylhydrazyl scavenging assay, hydrogen peroxide scavenging assay and reducing power assay. Overall butanol and methanol leaf extracts showed significant antioxidant free radical scavenging activity. The methanol and petroleum ether leaf extracts at a dose of 400 mg/kg showed the highest percent inhibition of 84.88 and 82.12, respectively in the carrageenan-induced rat paw edema model, whereas, in formalin-induced rat paw edema model the chloroform and methanol leaf extracts showed the highest percent inhibition of 65.68 and 63.34 at a dose of 400 mg/kg, respectively. In both the antiinflammatory models, indomethacin (standard, 40 mg/kg) was used for comparison with test extracts. The gas chromatography-mass spectrometry analysis of bioactive butanol and methanol extracts showed the presence of compounds like sterols (stigmasterol, β-sitosterol and γ-sitosterol) and phenolic compounds (phenol, 2,4-bis(1,1-dimethylethyl),2,4-ditert-butylphenol), which could be responsible for the pharmacological activities observed. These in vitro and in vivo studies indicated that the antiinflammatory and antioxidant potential of the methanol leaf extract of Acacia auriculiformis Benth. could due to the presence of high phenolic and sterol content.


  • Open Access

    A comprehensive review on phytopharmacological investigations of Acacia auriculiformis A.Cunn. ex Benth

    by Naresh Kumar Rangra, Subir Samanta, Kishanta Kumar Pradhan

    Acacia auriculiformis A.Cunn. ex Benth. is a perennial shrub having a wide range of medicinal potentials and is widely distributed throughout the world. It is being used traditionally to overcome various medical complications like sore eyes, aches, rheumatism, allergy, itching, and rashes. Besides, Acacia auriculiformis has been proven for many pharmacological activities like central nervous system depressant activity, antioxidant, antimicrobial, antimalarial, anti-filarial, cestocidal, antimutagenic, chemopreventive, spermicidal, wound healing, hepatoprotective and antidiabetic activity due to its low toxicity (LD50 = 3 741.7 mg/kg) and high efficacy. In addition, various phytochemical investigations reveal the presence of chief constituents as flavonoids (Auriculoside) and triterpenoid saponin glycosides (acaciasides- acaciaside A & B) in different parts of this plant. Since many years researchers have been carrying out various studies on this medicinal important shrub to elicit the various biological activities. This review attempts to highlight the pharmacognostical, phytochemical and pharmacological observations from 1965 to 2018 retrieved from SciFinder, Scientific journals, books, Google Scholar, and botanical electronic database websites. The various plant extracts evaluated for different pharmacological activities showed significant efficacy. Bioactive phytoconstituents isolated from various parts of the plant are highlighted. Pharmacognostical standardization of the plant done with various standard parameters is also reported. The low toxicity of this plant and the presence of major bioactive phytoconstituents like flavonoids and triterpenoid saponin glycosides are responsible for a therapeutic remedy for various diseases and pharmacological activities respectively. This review provides exhaustive information about the pharmacognostical, phytochemical, and pharmacological investigations of Acacia auriculiformis till date.


  • Open Access

    Wound healing activity of silibinin in mice

    by Sugato Banerjee, Rojalini Samanta, Ashok K Pattnaik, Kishanta K Pradhan, Beena K Mehta, Shakti P Pattanayak

    Background: Silibinin is a semi-purified fraction of silymarin contained in milk thistle (Silybum marianum Asteraceae). Primarily known for its hepatoprotective actions, silymarin may also stimulate epithelialization and reduce inflammation in excision wound. Previous studies show antioxidant, anti-inflammatory, and antimicrobial actions of silibinin. However, wound healing property of silibinin is not well studied. Objective: This study investigates wound healing activity of silibinin topical formulation. Materials and Methods: Wound healing activity of 0.2% silibinin gel was assessed by incision and excision wound models in mice. Animals were divided into gel base, silibinin gel, and Mega Heal gel® treated groups with six animals in each group. Wound contraction, wound tissue tensile strength, and hydroxyproline content were measured, and histopathological evaluation of wound tissue of all the above treatment groups was carried out. Results: Application of 0.2% silibinin hydrogel for 8 days led to 56.3% wound contraction compared to 64.6% using standard Mega Heal gel with a subsequent increase in hydroxyproline content, which was significantly higher (P < 0.001) over control animals showing 33.2% contraction. After 14 days, percentage of contraction reached 96.1%, 97.6%, and 86.7%, respectively. Wound tissue tensile strength with silibinin (223.55 ± 3.82 g) and standard (241.38 ± 2.49 g) was significantly higher (P < 0.001) than control (174.06 ± 5.75 g). Histopathology of silibinin and standard gel treated wound tissue showed more fibroblasts, fewer macrophage infiltration, and well-formed collagen fibers. Conclusion: Here, we show potent wound healing activity of silibinin hydrogel formulation.